Mometasone furoate delivered via Breezhaler and Twisthaler in patients with asthma

R. Buhl (Mainz, Germany), A. Tanase (Basel, Switzerland), M. Hosoe (Basel, Switzerland), W. Cao (New Jersey, United States of America), I. Demin (Basel, Switzerland), C. Bartels (Basel, Switzerland), J. Jauernig (Basel, Switzerland), D. Ziegler (Basel, Switzerland), F. Patalano (Basel, Switzerland), B. Hederer (Basel, Switzerland), F. Kanniess (Reinfeld, Germany), H. Tillmann (Basel, Switzerland)

Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session: Asthma: outcomes of clinical trials and cohorts
Session type: Thematic Poster
Number: 4254

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Buhl (Mainz, Germany), A. Tanase (Basel, Switzerland), M. Hosoe (Basel, Switzerland), W. Cao (New Jersey, United States of America), I. Demin (Basel, Switzerland), C. Bartels (Basel, Switzerland), J. Jauernig (Basel, Switzerland), D. Ziegler (Basel, Switzerland), F. Patalano (Basel, Switzerland), B. Hederer (Basel, Switzerland), F. Kanniess (Reinfeld, Germany), H. Tillmann (Basel, Switzerland). Mometasone furoate delivered via Breezhaler and Twisthaler in patients with asthma. 4254

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: